耶氏肺孢子菌病:修订版EORTC/MSGERC无HIV个体侵袭性真菌病定义依据
EORTC/MSGERC专家组基于宿主因素、临床影像学及真菌学检测,制定了适用于无HIV免疫抑制成人和儿童的 probable 与 proven 肺孢子菌病共识定义,并阐述其科学依据,旨在用于临床试验和流行病学研究。
要点
- proven PCP需临床影像学标准加组织或呼吸道标本镜检见耶氏肺孢子菌。
- probable PCP需宿主因素和临床影像学标准加呼吸道标本qPCR阳性或血清β-d-葡聚糖阳性。
- 肺外肺孢子菌病需受累组织镜检见病原体,最好联合PCR。
核心结论
- 修订的肺孢子菌病定义适用于无HIV的广泛免疫抑制患者的临床、诊断和流行病学研究。
研究设计与样本
- EORTC/MSGERC召集专家组制定共识定义,基于宿主因素、临床影像学及真菌学检测三联征,经公开咨询辩论调整。
主要发现
- proven PCP基于临床影像学标准加组织或呼吸道标本镜检见耶氏肺孢子菌。
- probable PCP基于宿主因素和临床影像学标准加呼吸道标本qPCR或血清β-d-葡聚糖阳性且排除其他侵袭性真菌病和假阳性。
- 肺外肺孢子菌病需受累组织镜检见病原体,最好联合PCR。
关键数值与推荐
- proven PCP:临床影像学标准加镜检见耶氏肺孢子菌。
- probable PCP:宿主因素和临床影像学标准加qPCR或β-d-葡聚糖阳性,排除其他侵袭性真菌病和假阳性。
- 肺外肺孢子菌病:受累组织镜检见病原体,最好联合PCR。
临床怎么用
- 该定义可用于无HIV免疫抑制患者的临床试验、流行病学研究和诊断评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pneumocystis jirovecii pneumonia (PCP) causes substantive morbidity in immunocompromised patients. The EORTC/MSGERC convened an expert group to elaborate consensus definitions for Pneumocystis disease for the purpose of interventional clinical trials and epidemiological studies and evaluation of diagnostic tests. METHODS: Definitions were based on the triad of host factors, clinical-radiologic features, and mycologic tests with categorization into probable and proven Pneumocystis disease, and to be applicable to immunocompromised adults and children without human immunodeficiency virus (HIV). Definitions were formulated and their criteria debated and adjusted after public consultation. The definitions were published within the 2019 update of the EORTC/MSGERC Consensus Definitions of Invasive Fungal Disease. Here we detail the scientific rationale behind the disease definitions. RESULTS: The diagnosis of proven PCP is based on clinical and radiologic criteria plus demonstration of P. jirovecii by microscopy using conventional or immunofluorescence staining in tissue or respiratory tract specimens. Probable PCP is defined by the presence of appropriate host factors and clinical-radiologic criteria, plus amplification of P. jirovecii DNA by quantitative real-time polymerase chain reaction (PCR) in respiratory specimens and/or detection of β-d-glucan in serum provided that another invasive fungal disease and a false-positive result can be ruled out. Extrapulmonary Pneumocystis disease requires demonstration of the organism in affected tissue by microscopy and, preferably, PCR. CONCLUSIONS: These updated definitions of Pneumocystis diseases should prove applicable in clinical, diagnostic, and epidemiologic research in a broad range of immunocompromised patients without HIV.
引用
- Lagrou K, Chen S, Masur H, et al. Pneumocystis jirovecii Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus. Clin Infect Dis. 2021. PMID: 33709126. doi:10.1093/cid/ciaa1805
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。